A 405-kb Cosmid Contig and HindIII Restriction Map of the Progressive Myoclonus Epilepsy Type 1 (EPM1) Candidate Region in 21q22.3

Genomics ◽  
1995 ◽  
Vol 29 (1) ◽  
pp. 288-290 ◽  
Author(s):  
Ronald G. Lafrenière ◽  
Pieter J. de Jong ◽  
Guy A. Rouleau
Genomics ◽  
1998 ◽  
Vol 52 (2) ◽  
pp. 201-204 ◽  
Author(s):  
Ya-Gang Xie ◽  
Daniel Rochefort ◽  
Bernard Brais ◽  
Heidi Howard ◽  
Fei-Yu Han ◽  
...  

1997 ◽  
Vol 15 (3) ◽  
pp. 298-302 ◽  
Author(s):  
Ronald G. Lafreniére ◽  
Daniel L. Rochefort ◽  
Nathalie Chrétien ◽  
Johanna M. Rommens ◽  
Jeffrey I. Cochius ◽  
...  

2021 ◽  
Vol 122 ◽  
pp. 108157
Author(s):  
Marja Äikiä ◽  
Jelena Hyppönen ◽  
Esa Mervaala ◽  
Reetta Kälviäinen

Cells ◽  
2019 ◽  
Vol 8 (1) ◽  
pp. 70 ◽  
Author(s):  
Eva Žerovnik

Human stefin B is a protease inhibitor from the family of cystatins. It was reported that it forms oligomers in cells. We have shown that it has a role in cell’s response to misfolded proteins. We also have shown that its oligomers bind amyloid-beta (Aβ). Here, we discuss ways, how stefin B could reduce build-up of protein aggregates by other proteins and consequently reduces ROS and, how this might be connected to autophagy. When overexpressed, stefin B forms protein aggregates itself and these protein aggregates induce autophagy. Similarly, cystatin C was shown to bind Aβ and to induce autophagy. It is also suggested how more knowledge about the role of stefin B in a cell’s response to misfolded proteins could be used to modulate progressive myoclonus epilepsy of type 1 EPM1 disease.


Sign in / Sign up

Export Citation Format

Share Document